Skip to main content
CTVA logo

CTVA · Corteva, Inc.

Track CTVA — free
$9.46 +0.03 (+0.32%)
Market Cap
$6.29B
Shares
667.32M
Volume · Nov 13 28.9M Avg daily vol (3M) 18.59M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$9.43 Open$9.11 Day$9.01–9.50 52W close$9.19–90.51 Avg vol 30d29.6M Short int51.0M · 7.6% of shares · 2.7d Short vol29% Last earningsNov 12, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 12

Up next

Feb 3, 2027 Est · unconfirmed · in 11 wks

Latest documents

2026
Nov 12
Earnings call
Brazil weakness cuts EBITDA outlook

Corteva cut 2026 operating EBITDA outlook to $1.1 to $1.125 billion from about $1.3 billion due to worsening Brazil conditions. Third-quarter net sales were $1.6 billion, down 9%, and operating EBITDA was $222 million, down 17%.

2 source passages
At our investor day in September, we estimated 2026 standalone operating EBITDA of about $1.3 billion. Today, we are updating that estimate to a range of $1.1 to $1.125 billion for the full year. For the third quarter, net sales were $1.6 billion, down 9% versus the prior year on both a reported and organic basis. Operating EBITDA was $222 million, down 17%, and operating EBITDA margin was 14%, down 140 basis points. Open the document at this passage
Nov 12
Current report 8-K
Seed Business separation completes as Vylor becomes independent

Corteva completed the separation of its Seed Business into independent publicly traded Vylor through a pro rata dividend in-kind on October 1, 2026, leaving New Corteva as the Crop Protection Business.

Read from the first part of this long document
2 source passages
On October 1, 2026, Corteva completed the separation of its Seed Business into an independent publicly traded company, Vylor, through a pro rata dividend in-kind of all of the then-issued and outstanding shares of common stock of Vylor to holders of the Company’s common stock as of the close of business on September 24, 2026. The historical financial statements of New Corteva, the Company’s Crop Protection Business, are comprised solely of the accompanying Combined Financial Statements and notes which present the results of operations, financial position and cash flows of New Corteva, and have been derived from the combined financial statements and accounting records of Corteva using the historical results of operations and historical basis of assets and liabilities of Corteva. Open the document at this passage
Nov 12
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Seed separation completed as third-quarter sales fell 6%

Corteva completed its Seed separation on October 1, 2026, creating Vylor Inc. Third-quarter net sales fell 6% to $2,458 million and operating EBITDA turned negative at $(68) million, while nine-month sales rose 2% to $13,742 million.

Revenue $2.46B ▼ 6.1% Net loss $570M Diluted EPS -$0.85
Read from the MD&A section
4 source passages
On October 1, 2026, the company completed its previously announced separation into two independent, publicly traded companies through the separation of Corteva’s seed operating segment into an independent, publicly traded company, Vylor Inc. The company reported net sales of $2,458 million, down 6 percent versus the same quarter last year, reflecting a 6 percent decrease in volume and a 2 percent decrease in price, partially offset by a 2 percent favorable impact from currency. Operating EBITDA was $(68) million for the three months ended September 30, 2026, down from $49 million for the three months ended September 30, 2025, primarily driven by Crop Protection pricing pressure, lower volumes, higher information technology and legal support fees, and increased investment in research and development, partially offset by ongoing cost and productivity actions, net royalty improvements, and favorable currency impacts. The company reported net sales of $13,742 million, up 2 percent versus the same period last year, reflecting a 2 percent favorable impact from currency. Open the document at this passage
Nov 12
Current report 8-K Events of Nov 11
Third-quarter sales fall 9%; Brazil weakness cuts outlook

Corteva reported third-quarter net sales of $1.59B, down 9%, as Brazil market conditions weakened. Full-year Adjusted Pro Forma Operating EBITDA guidance was lowered to between $1.1 billion and $1.125 billion.

Financial results Read from the first part of this long document
3 source passages
3Q 2026 Results Overview Net Sales Loss from Cont. Ops (After Tax) EPS Pro Forma GAAP $1.59B $(54)M $(0.08) vs. 3Q 2025 (9)% (190)% (189)% Reflecting these market dynamics, primarily the deterioration in Brazil, the Company updated its full-year 2026 guidance³. Adjusted Pro Forma Operating EBITDA¹ is now expected to be between $1.1 billion and $1.125 billion, and Adjusted Pro Forma Operating EPS1 is expected to be between $0.76 and $0.80 per share. Open the document at this passage
Nov 10
Late filing notice NT 10-Q
Corteva and EIDP delay filing, expect higher seasonal loss

Corteva and EIDP delayed their September 30, 2026 quarterly report after the October 1, 2026 seed-segment spin-off. They expect a higher seasonal loss than in 2025 and plan to issue results before the November 12, 2026 earnings call.

3 source passages
Corteva, Inc. and EIDP, Inc. (the “Companies”) are unable to file their Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026 by the prescribed due date without unreasonable effort or expense as the Companies require additional time to complete certain processes and procedures related to the required reporting resulting from the spin-off of the Companies’ seed operating segment completed on October 1, 2026 (the “Separation”). As a result, the Companies expect a higher seasonal loss as compared to the same period in 2025. Corteva expects to issue financial results in advance of the scheduled earnings call on November 12, 2026. Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$17.65B
Trailing 12 months
Net income (TTM)
$753.00M
Trailing 12 months
Revenue growth YoY
-6.1%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
8.2
Trailing earnings · reciprocal yield 12.2%
FCF yield
-2.4%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$475.00M
Latest balance sheet
Dividend yield
7.6%
Trailing 12 months
Shares change YoY
-1.6%
Year over year · fewer shares
Price change (1Y)
-85.8%
Trailing year
Short interest
7.6%
Latest settlement · 2.7 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Nov 12, 2026
Q3 FY26

TL;DR. New-product growth, regional organic growth outside Latin America, productivity and year-to-date margin expansion supported the business. However, Brazil-driven weakness caused a sharp third-quarter decline, reduced full-year EBITDA guidance and implied fourth-quarter EBITDA of about half of 2025 levels.

Bullish
  • + New product volumes grew 20% in the quarter, with growth in every region.
  • + North America, EMEA and Asia Pacific delivered organic growth in the quarter.
  • + Year-to-date operating EBITDA was essentially flat and margins expanded 30 basis points despite more than approximately $230 million of pricing headwinds.
  • + Cost-of-goods productivity and lower SG&A spending more than covered increased R&D investment, producing a $67 million quarterly benefit.
  • + The board declared Corteva’s first quarterly dividend as a standalone company.
  • + Corteva remained on track for a targeted year-end cash position of roughly $1.5 billion.
Bearish
  • − Third-quarter net sales fell 9%, operating EBITDA fell 17% and operating EBITDA margin contracted 140 basis points.
  • − Latin America organic sales declined 31% in the third quarter.
  • − Latin American volume decreased 24% due to elevated channel inventory and delayed purchasing, while price declined 7% amid competitive pressure on mature molecules.
  • − Full-year operating EBITDA guidance was reduced from about $1.3 billion to $1.1 billion–$1.125 billion.
  • − Fourth-quarter operating EBITDA is expected to be about half of 2025 levels because of Brazil’s significance to fourth-quarter results.
  • − Elevated Brazil channel inventory is expected to create an approximately $100 million full-year EBITDA impact.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −86%
below
Price vs 50-day avg −75%
below
RSI (14) 14
oversold
MACD trend Positive
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −27%
trailing
6-month return −88%
trailing
YTD return −86%
this year
Relative strength −89%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $37 › 200d $70 — 200d above 50d
Institutional flow Accumulating
1,349 of 1,508 funds reported for Sep 30 · net +7.1M sh shares · +77 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
7.64% of shares out · ▲ +32.2% MoM · 2.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
1,508 holders — near 3-yr high, broad support
Squeeze score 65
elevated · 0–100
Fundamentals
Excellent
Revenue growth +3%
Y/Y
EPS growth +23%
Y/Y
Free cash flow $2.2B
Valuation P/E 8.2
below peers
Buyback $5.0B
authorized
Balance sheet $1.9B
net cash
Quant / Vol
risk profile
Very High
Volatility 93%
annualized · 1-yr
Max drawdown −90%
past year
ATR 13.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 3 of last 6
Latest guidance · from the Earnings Call filed Nov 12, 2026
year-end
Year-end cash position $1.5B
full year
Operating EBITDA Non-GAAP Lowered $1.1B – $1.13B
Jul 30, 2026 $4.1B – $4.3B changed to Nov 12, 2026 $1.1B – $1.13B
Full-year EBITDA impact related to elevated channel inventory Non-GAAP $100M
Operating EPS $0.76 – $0.80
prior FY $1.60 midpoint −51.3% Y/Y
Operating EPS growth 3%
Reduction in our guide for the full year Non-GAAP $200M
Reduction in full-year EBITDA $200M
for the year
Operating EBITDA margin Non-GAAP 15%
by the end of the year
Cash position $1.5B
a year
CapEx $200M
Previous outlook earlier release · from the Earnings Call filed Jul 31, 2026

Still-open targets the latest release did not restate under the same label.

Operating EPS · full year 2026 $3.60 – $3.80
Operating EBITDA · full year $4.1B – $4.3B
Operating EBITDA margin · full year 22.5% – 23.5%
Operating EPS · full year $3.60 – $3.80
New product revenue (full year) · this year $2B
Guided vs delivered · last 6 settled
Net sales full-year 2024
guided $17.4B – $17.7B
$16.91B Miss −3.7%
Net sales full-year 2023
guided $17B – $17.3B
$17.23B In line
Net sales full year 2022
guided $17.2B – $17.5B
$17.46B In line
Operating EPS for the year
guided $2.30 – $2.50
$1.58 Miss −34.2%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−86% Bearish
Price vs 50-day avg
−75% Bearish
RSI (14)
14 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $37 › 200d $70 — 200d above 50d
Institutional flow Accumulating
1,349 of 1,508 funds reported for Sep 30 · net +7.1M sh shares · +77 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
7.64% of shares out · ▲ +32.2% MoM · 2.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
1,508 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $9 Now $9 · 0% Range high $91
vs 200-day avg -86% vs 50-day avg -75%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted Pro Forma Base Income Tax Rate From Continuing Operations (Non-GAAP) non-GAAP 14.7% Nine Months Ended September 30 —
Adjusted Pro Forma Operating Earnings (Loss) (Non-GAAP) non-GAAP $513M Nine Months Ended September 30 —
Adjusted Pro Forma Operating Earnings (Loss) Per Share (Non-GAAP) non-GAAP $0.76 Nine Months Ended September 30 —
Adjusted Pro Forma Operating EBITDA (Non-GAAP) non-GAAP $943M Nine Months Ended September 30 —
Adjusted Pro Forma Operating EBITDA margin non-GAAP 17.6% YTD 2026 —
Asia Pacific organic sales growth non-GAAP 5% third quarter of 2026 —
Asia Pacific price growth -2% third quarter of 2026 —
Asia Pacific volume growth 7% third quarter of 2026 —
EMEA organic sales growth non-GAAP 14% third quarter of 2026 —
Latin America organic sales growth non-GAAP -31% third quarter of 2026 —
Latin America price growth -7% third quarter of 2026 —
Latin America volume growth -24% third quarter of 2026 —
North America organic sales growth non-GAAP 7% third quarter of 2026 —
North America volume growth 19% third quarter of 2026 —
Organic Change 1(Non-GAAP) non-GAAP -9% Q3 2026 vs. Q3 2025 —
Pro Forma Operating Earnings (Loss) (Non-GAAP) non-GAAP $528M Nine Months Ended September 30 —
Pro Forma Operating EBITDA (Non-GAAP) non-GAAP $960M Nine Months Ended September 30, 2026 —
Pro Forma Organic Sales (Non-GAAP) non-GAAP $5.2B Nine Months Ended September 30, 2026 —
Average Price Paid per Share $80.77 the three months ended June 30, 2026 filing —
Segment operating EBITDA - Total $2.31B the three months ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Income (loss) from continuing operations after income taxes 1.22B
+408M Provision for (benefit from) income taxes on continuing operations
+339M Depreciation and amortization
-27M Interest income
+47M Interest expense
+75M Exchange (gains) losses - net
+17M Non-operating (benefits) costs - net
+21M Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges
+85M Significant items (benefit) charge
+79M Separation costs
+47M Corporate expenses
= Segment operating EBITDA - Total 2.31B
Shares repurchased and retired under 2024 Share Buyback Plan 3,095,000 the three months ended June 30, 2026 filing —
Total cost of shares repurchased under 2024 Share Buyback Plan (excluding excise taxes) $250M the three months ended June 30, 2026 filing —
Total Number of Shares Purchased 3,095,201 the three months ended June 30, 2026 filing —
Base income tax rate from continuing operations (Non-GAAP) non-GAAP 20.1% Six Months Ended June 30 —
Diluted Shares 671.6M Six Months Ended June 30 —
Operating Earnings (Loss) (Non-GAAP) non-GAAP $2.55B Six Months Ended June 30 —
Operating EPS non-GAAP $3.8 1H 2026 —
Segment operating EBITDA - Crop Protection non-GAAP $776M 1H 2026 —
Segment operating EBITDA - Seed non-GAAP $3B 1H 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Agricultural Inputs — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CTVA
Corteva, Inc.
this stock
$6.29B -85.9% +2.9% 8.2 7.6%
NTR
Nutrien Ltd.
$33.78B +15.4% — — 1.8%
CF
CF Industries Holdings, Inc.
$18.30B +61.7% +19.3% 8.9 6.1%
YARIY
Yara International ASA
$10.87B +4.7% — — 0.0%
MOS
Mosaic Co
$6.97B -9.0% +8.4% — 11.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
1,476
% held
90.1%
Reported
1,349 of 1,508
Top holder
FMR LLC
Held Float
View
Held by Funds
Fund positions
893
View
Short & Settlement
Short Interest Rising
Shares short
51.0M
Days to cover
2.7d
Change
+12.4M sh
View
Short Volume
Short vol %
29%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
9
Value
$120
As of
Oct 14, 2026
View
Off-Exchange
Off-exchange %
43.7%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Gary Peters
Amount
$15.0K–$50.0K
Traded
Apr 23, 2026
View
Financials
Financials
Revenue (FY)
$17.4B
Net income (FY)
$1.1B
EPS diluted
$1.60
View
Buybacks
Authorized · 2 programs
$5.0B
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 12, 2026
This year
41

Corteva completed the separation of its Seed Business into independent publicly traded Vylor through a pro rata dividend in-kind on October 1, 2026, leaving New Corteva as the Crop Protection Business.

View
Proposed Sales
Value
$636.2K
Shares
8.3K
Filed
Feb 20, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 12, 2026
View
Investor Relations
Latest news
Corteva Declares Quarterly Divide…
Published
Oct 23, 2026
View

Performance

5D 20D 120D MTD YTD
CTVA -20.8% -26.8% -88.1% -19.0% -85.9%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY -23.4% -25.6% -88.6% -18.8% -96.6%

Capital returns

Latest dividend
$0.18 / share · ex Sep 1, 2026
Declared · upcoming
$0.05 / share · ex Dec 1, 2026
Raised 5.9%
Paid (TTM)
$0.72 / share · 4 payouts
Dividend yield (TTM, derived)
7.64%
Full dividend history
Buyback programs · 2 active · as of Nov 19, 2024
Authorized (total)
$5.00B
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1755672 CUSIP 22052L104 13F (30d) 1110 filings 1029 filers Visit website Investor relations